Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT

Authors

Keywords

Journal

Volume 224, Issue 1, Pages 7-15

Publisher

Elsevier BV

Online

2013-10-19

DOI

10.1016/j.toxlet.2013.10.008

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now